Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

Fig. 1

A Incidence of SARS-CoV-2 infection in pediatric cancer patients in 2020 and early 2021. B The duration of SARS-CoV-2 replication was calculated as the interval between the first and last positive results. The dotted line marks day 16, which was the median length of PCR positivity. C Time to clearance of SARS-CoV-2 replication was calculated as the interval between the first positive and first negative results. The dotted line marks the median time to a first negative result on day 22. D Comparison of the probability of SARS-CoV-2 negativity between patients with absolute neutrophil counts (ANCs) below and above 1200/µL at diagnosis

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us